Cardurion logo - click to return to the homepage

Cardurion Pharmaceuticals Announces Formation of Scientific and Clinical Advisory Board

CAMBRIDGE, MASS. – [June 26, 2018] – Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced that it has assembled world-class Scientific and Clinical Advisory Boards. “Cardiovascular disease is the leading cause of death in both men and women and accounts for one-third of […]

This site uses cookies and third-party scripts to provide certain services. View Privacy Policy

Skip to content